Latest / JIJI English News-時事通信英語ニュース-

Japan's Shionogi to Buy U.S. Bioventure for 2 B. Dollars
Major Japanese drugmaker Shionogi & Co. has said that it will acquire U.S. biopharmaceutical company IntraBio Inc. for 2 billion dollars as part of efforts to strengthen its rare disease drug business.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.